{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,18]],"date-time":"2026-01-18T03:37:07Z","timestamp":1768707427742,"version":"3.49.0"},"reference-count":31,"publisher":"Springer Science and Business Media LLC","issue":"6","license":[{"start":{"date-parts":[[2021,12,26]],"date-time":"2021-12-26T00:00:00Z","timestamp":1640476800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2021,12,26]],"date-time":"2021-12-26T00:00:00Z","timestamp":1640476800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"name":"Justus-Liebig-Universit\u00e4t Gie\u00dfen"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Int J Cardiovasc Imaging"],"abstract":"<jats:title>Abstract<\/jats:title><jats:p>Epicardial fat tissue (EFT) is a highly metabolically active fat depot surrounding the heart and coronary arteries that is related to early atherosclerosis and adverse cardiac events. We aimed to investigate the relationship between the amount of EFT and preexisting cardiac conduction abnormalities (CCAs) and the need for new postinterventional pacemaker in patients with severe aortic stenosis planned for transcatheter aortic valve implantation (TAVI). A total of 560 consecutive patients (54% female) scheduled for TAVI were included in this retrospective study. EFT volume was measured via a fully automated artificial intelligence software (QFAT) using computed tomography (CT) performed before TAVI. Baseline CCAs [first-degree atrioventricular (AV) block, right bundle branch block (RBBB), and left bundle branch block (LBBB)] were diagnosed according to 12-lead ECG before TAVI. Aortic valve calcification was determined by the Agatston score assessed in the pre-TAVI CT. The median EFT volume was 129.5\u00a0ml [IQR 94\u2013170]. Baseline first-degree AV block was present in 17%, RBBB in 10.4%, and LBBB in 10.2% of the overall cohort. In adjusted logistic regression analysis, higher EFT volume was associated with first-degree AV block (OR 1.006 [95% CI 1.002\u20131.010]; p\u2009=\u20090.006) and the need for new pacemaker implantation after TAVI (OR 1.005 [95% CI 1.0\u20131.01]; p\u2009=\u20090.035) but not with the presence of RBBB or LBBB. EFT volume did not correlate with the Agatston score of the aortic valve. Greater EFT volume is associated independently with preexisting first-degree AV block and new pacemaker implantation in patients undergoing TAVI. It may play a causative role in degenerative processes and the susceptibility of the AV conduction system.<\/jats:p>","DOI":"10.1007\/s10554-021-02502-x","type":"journal-article","created":{"date-parts":[[2021,12,26]],"date-time":"2021-12-26T10:02:30Z","timestamp":1640512950000},"page":"1399-1406","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":11,"title":["Epicardial fat volume is associated with preexisting atrioventricular conduction abnormalities and increased pacemaker implantation rate in patients undergoing transcatheter aortic valve implantation"],"prefix":"10.1007","volume":"38","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-5556-8670","authenticated-orcid":false,"given":"Maren","family":"Weferling","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Andreas","family":"Rolf","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ulrich","family":"Fischer-Rasokat","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Christoph","family":"Liebetrau","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Matthias","family":"Renker","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yeoung-Hoon","family":"Choi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Christian W.","family":"Hamm","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Damini","family":"Dey","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Won-Keun","family":"Kim","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2021,12,26]]},"reference":[{"issue":"11","key":"2502_CR1","doi-asserted-by":"publisher","first-page":"450","DOI":"10.1016\/j.tem.2011.07.003","volume":"22","author":"G Iacobellis","year":"2011","unstructured":"Iacobellis G, Bianco AC (2011) Epicardial adipose tissue: emerging physiological, pathophysiological and clinical features. Trends Endocrinol Metab 22(11):450\u2013457. https:\/\/doi.org\/10.1016\/j.tem.2011.07.003","journal-title":"Trends Endocrinol Metab"},{"key":"2502_CR2","doi-asserted-by":"publisher","DOI":"10.3390\/ijms20235989","author":"AC Villasante Fricke","year":"2019","unstructured":"Villasante Fricke AC, Iacobellis G (2019) Epicardial adipose tissue: clinical biomarker of cardio-metabolic risk. Int J Mol Sci. https:\/\/doi.org\/10.3390\/ijms20235989","journal-title":"Int J Mol Sci"},{"issue":"3","key":"2502_CR3","doi-asserted-by":"publisher","first-page":"253","DOI":"10.1111\/j.1467-789X.2006.00293.x","volume":"8","author":"SW Rabkin","year":"2007","unstructured":"Rabkin SW (2007) Epicardial fat: properties, function and relationship to obesity. Obes Rev 8(3):253\u2013261. https:\/\/doi.org\/10.1111\/j.1467-789X.2006.00293.x","journal-title":"Obes Rev"},{"issue":"20","key":"2502_CR4","doi-asserted-by":"publisher","first-page":"2460","DOI":"10.1161\/01.CIR.0000099542.57313.C5","volume":"108","author":"T Mazurek","year":"2003","unstructured":"Mazurek T, Zhang L, Zalewski A, Mannion JD, Diehl JT, Arafat H, Sarov-Blat L, O\u2019Brien S, Keiper EA, Johnson AG, Martin J, Goldstein BJ, Shi Y (2003) Human epicardial adipose tissue is a source of inflammatory mediators. Circulation 108(20):2460\u20132466. https:\/\/doi.org\/10.1161\/01.CIR.0000099542.57313.C5","journal-title":"Circulation"},{"issue":"5","key":"2502_CR5","doi-asserted-by":"publisher","first-page":"490","DOI":"10.1093\/ehjci\/jex314","volume":"19","author":"J Mancio","year":"2018","unstructured":"Mancio J, Azevedo D, Saraiva F, Azevedo AI, Pires-Morais G, Leite-Moreira A, Falcao-Pires I, Lunet N, Bettencourt N (2018) Epicardial adipose tissue volume assessed by computed tomography and coronary artery disease: a systematic review and meta-analysis. Eur Heart J Cardiovasc Imaging 19(5):490\u2013497. https:\/\/doi.org\/10.1093\/ehjci\/jex314","journal-title":"Eur Heart J Cardiovasc Imaging"},{"key":"2502_CR6","doi-asserted-by":"publisher","DOI":"10.3390\/ijms21228866","author":"G Conceicao","year":"2020","unstructured":"Conceicao G, Martins D, Miranda IM, Leite-Moreira AF, Vitorino R, Falcao-Pires I (2020) Unraveling the role of epicardial adipose tissue in coronary artery disease: partners in crime? Int J Mol Sci. https:\/\/doi.org\/10.3390\/ijms21228866","journal-title":"Int J Mol Sci"},{"issue":"5","key":"2502_CR7","doi-asserted-by":"publisher","first-page":"605","DOI":"10.1161\/CIRCULATIONAHA.107.743062","volume":"117","author":"GA Rosito","year":"2008","unstructured":"Rosito GA, Massaro JM, Hoffmann U, Ruberg FL, Mahabadi AA, Vasan RS, O\u2019Donnell CJ, Fox CS (2008) Pericardial fat, visceral abdominal fat, cardiovascular disease risk factors, and vascular calcification in a community-based sample: the Framingham Heart Study. Circulation 117(5):605\u2013613. https:\/\/doi.org\/10.1161\/CIRCULATIONAHA.107.743062","journal-title":"Circulation"},{"issue":"2","key":"2502_CR8","doi-asserted-by":"publisher","first-page":"267","DOI":"10.1007\/s10554-018-1477-z","volume":"35","author":"A Coisne","year":"2019","unstructured":"Coisne A, Ninni S, Ortmans S, Davin L, Kasprzak K, Longere B, Seunes C, Coppin A, Mouton S, Ridon H, Klein C, Noirot-Cosson B, Staels B, Lancellotti P, Montaigne D, Pontana F (2019) Epicardial fat amount is associated with the magnitude of left ventricular remodeling in aortic stenosis. Int J Cardiovasc Imaging 35(2):267\u2013273. https:\/\/doi.org\/10.1007\/s10554-018-1477-z","journal-title":"Int J Cardiovasc Imaging"},{"key":"2502_CR9","doi-asserted-by":"publisher","DOI":"10.1007\/s40520-020-01681-2","author":"M Conte","year":"2020","unstructured":"Conte M, Petraglia L, Campana P, Gerundo G, Caruso A, Grimaldi MG, Russo V, Attena E, Leosco D, Parisi V (2020) The role of inflammation and metabolic risk factors in the pathogenesis of calcific aortic valve stenosis. Aging Clin Exp Res. https:\/\/doi.org\/10.1007\/s40520-020-01681-2","journal-title":"Aging Clin Exp Res"},{"key":"2502_CR10","doi-asserted-by":"publisher","first-page":"60","DOI":"10.1016\/j.atherosclerosis.2018.08.029","volume":"277","author":"KI Cho","year":"2018","unstructured":"Cho KI, Sakuma I, Sohn IS, Jo SH, Koh KK (2018) Inflammatory and metabolic mechanisms underlying the calcific aortic valve disease. Atherosclerosis 277:60\u201365. https:\/\/doi.org\/10.1016\/j.atherosclerosis.2018.08.029","journal-title":"Atherosclerosis"},{"issue":"24","key":"2502_CR11","doi-asserted-by":"publisher","first-page":"2571","DOI":"10.1001\/jama.2009.888","volume":"301","author":"SKM Cheng","year":"2009","unstructured":"Cheng SKM, Larson MG, McCabe EL, Newton-Cheh C, Levy D, Benjamin EJ, Vasan RS, Wang TJ (2009) Long-term outcomes in individuals with prolonged PR interval or first-degree atrioventricular block. JAMA 301(24):2571\u20132577","journal-title":"JAMA"},{"key":"2502_CR12","volume-title":"First degree heart block","author":"SH Oldroyd","year":"2021","unstructured":"Oldroyd SH, Quintanilla Rodriguez B, Makaryus AN (2021) First degree heart block. StatPearls Publishing, Treasure Island"},{"key":"2502_CR13","volume-title":"Right bundle branch block","author":"WT Harkness","year":"2021","unstructured":"Harkness WT, Hicks M (2021) Right bundle branch block. StatPearls, Treasure Island"},{"key":"2502_CR14","doi-asserted-by":"publisher","DOI":"10.1161\/circep.119.008239","author":"NY Tan","year":"2020","unstructured":"Tan NY, Witt CM, Oh JK, Cha Y-M (2020) Left bundle branch block. Circ Arrhythm Electrophysiol. https:\/\/doi.org\/10.1161\/circep.119.008239","journal-title":"Circ Arrhythm Electrophysiol"},{"key":"2502_CR15","doi-asserted-by":"publisher","unstructured":"Joint Task Force on the Management of Valvular Heart Disease of the European Society of Cardiology, European Association for Cardio-Thoracic Surgeons, Vahanian A, Alfieri O, Andreotti F, Antunes MJ, Baron-Esquivias G, Baumgartner H, Borger MA, Carrel TP, De Bonis M, Evangelista A, Falk V, Iung B, Lancellotti P, Pierard L, Price S, Schafers HJ, Schuler G, Stepinska J, Swedberg K, Takkenberg J, Von Oppell UO, Windecker S, Zamorano JL, Zembala M (2012) Guidelines on the management of valvular heart disease (version 2012). Eur Heart J 33(19):2451\u20132496.https:\/\/doi.org\/10.1093\/eurheartj\/ehs109","DOI":"10.1093\/eurheartj\/ehs109"},{"issue":"3","key":"2502_CR16","doi-asserted-by":"publisher","first-page":"e231","DOI":"10.4244\/EIJ-D-19-00236","volume":"15","author":"WK Kim","year":"2019","unstructured":"Kim WK, Renker M, Rolf A, Fischer-Rasokat U, Wiedemeyer J, Doss M, Mollmann H, Walther T, Nef H, Hamm CW, Liebetrau C (2019) Annular versus supra-annular sizing for TAVI in bicuspid aortic valve stenosis. EuroIntervention 15(3):e231\u2013e238. https:\/\/doi.org\/10.4244\/EIJ-D-19-00236","journal-title":"EuroIntervention"},{"issue":"6","key":"2502_CR17","doi-asserted-by":"publisher","DOI":"10.1148\/ryai.2019190045","volume":"1","author":"F Commandeur","year":"2019","unstructured":"Commandeur F, Goeller M, Razipour A, Cadet S, Hell MM, Kwiecinski J, Chen X, Chang HJ, Marwan M, Achenbach S, Berman DS, Slomka PJ, Tamarappoo BK, Dey D (2019) Fully automated CT quantification of epicardial adipose tissue by deep learning: a multicenter study. Radiol Artif Intell 1(6):e190045. https:\/\/doi.org\/10.1148\/ryai.2019190045","journal-title":"Radiol Artif Intell"},{"issue":"1","key":"2502_CR18","doi-asserted-by":"publisher","first-page":"136","DOI":"10.1016\/j.atherosclerosis.2009.08.032","volume":"209","author":"D Dey","year":"2010","unstructured":"Dey D, Wong ND, Tamarappoo B, Nakazato R, Gransar H, Cheng VY, Ramesh A, Kakadiaris I, Germano G, Slomka PJ, Berman DS (2010) Computer-aided non-contrast CT-based quantification of pericardial and thoracic fat and their associations with coronary calcium and metabolic syndrome. Atherosclerosis 209(1):136\u2013141. https:\/\/doi.org\/10.1016\/j.atherosclerosis.2009.08.032","journal-title":"Atherosclerosis"},{"issue":"10","key":"2502_CR19","doi-asserted-by":"publisher","first-page":"784","DOI":"10.1016\/j.jacc.2010.03.071","volume":"56","author":"MO Al Chekakie","year":"2010","unstructured":"Al Chekakie MO, Welles CC, Metoyer R, Ibrahim A, Shapira AR, Cytron J, Santucci P, Wilber DJ, Akar JG (2010) Pericardial fat is independently associated with human atrial fibrillation. J Am Coll Cardiol 56(10):784\u2013788. https:\/\/doi.org\/10.1016\/j.jacc.2010.03.071","journal-title":"J Am Coll Cardiol"},{"issue":"3","key":"2502_CR20","doi-asserted-by":"publisher","first-page":"230","DOI":"10.1161\/CIRCEP.110.957241","volume":"3","author":"O Batal","year":"2010","unstructured":"Batal O, Schoenhagen P, Shao M, Ayyad AE, Van Wagoner DR, Halliburton SS, Tchou PJ, Chung MK (2010) Left atrial epicardial adiposity and atrial fibrillation. Circ Arrhythm Electrophysiol 3(3):230\u2013236. https:\/\/doi.org\/10.1161\/CIRCEP.110.957241","journal-title":"Circ Arrhythm Electrophysiol"},{"issue":"5","key":"2502_CR21","doi-asserted-by":"publisher","first-page":"314","DOI":"10.1016\/j.acvd.2018.11.011","volume":"112","author":"A Mirolo","year":"2019","unstructured":"Mirolo A, Viart G, Savoure A, Godin B, Raitiere O, Eltchaninoff H, Anselme F (2019) Epicardial fat thickness predicts atrial fibrillation recurrence after a first pulmonary vein isolation procedure using a second-generation cryoballoon. Arch Cardiovasc Dis 112(5):314\u2013322. https:\/\/doi.org\/10.1016\/j.acvd.2018.11.011","journal-title":"Arch Cardiovasc Dis"},{"issue":"2","key":"2502_CR22","doi-asserted-by":"publisher","first-page":"E45","DOI":"10.25011\/cim.v38i1.22575","volume":"38","author":"WC Hung","year":"2015","unstructured":"Hung WC, Tang WH, Wang CP, Lu LF, Chung FM, Lu YC, Hsu CC, Tsai IT, Jhuo SJ, Lai WT, Lee YJ, Ya TH (2015) Increased epicardial adipose tissue volume is associated with PR interval prolongation. Clin Investig Med 38(2):E45-52. https:\/\/doi.org\/10.25011\/cim.v38i1.22575","journal-title":"Clin Investig Med"},{"issue":"4","key":"2502_CR23","doi-asserted-by":"publisher","first-page":"645","DOI":"10.1016\/j.jelectrocard.2018.04.009","volume":"51","author":"SJ Jhuo","year":"2018","unstructured":"Jhuo SJ, Hsieh TJ, Tang WH, Tsai WC, Lee KT, Yen HW, Lai WT (2018) The association of the amounts of epicardial fat, P wave duration, and PR interval in electrocardiogram. J Electrocardiol 51(4):645\u2013651. https:\/\/doi.org\/10.1016\/j.jelectrocard.2018.04.009","journal-title":"J Electrocardiol"},{"issue":"2","key":"2502_CR24","doi-asserted-by":"publisher","first-page":"129","DOI":"10.1016\/j.jacc.2014.04.033","volume":"64","author":"GC Siontis","year":"2014","unstructured":"Siontis GC, Juni P, Pilgrim T, Stortecky S, Bullesfeld L, Meier B, Wenaweser P, Windecker S (2014) Predictors of permanent pacemaker implantation in patients with severe aortic stenosis undergoing TAVR: a meta-analysis. J Am Coll Cardiol 64(2):129\u2013140. https:\/\/doi.org\/10.1016\/j.jacc.2014.04.033","journal-title":"J Am Coll Cardiol"},{"key":"2502_CR25","doi-asserted-by":"publisher","first-page":"85","DOI":"10.3389\/fcvm.2018.00085","volume":"5","author":"A Mangieri","year":"2018","unstructured":"Mangieri A, Montalto C, Pagnesi M, Lanzillo G, Demir O, Testa L, Colombo A, Latib A (2018) TAVI and post procedural cardiac conduction abnormalities. Front Cardiovasc Med 5:85. https:\/\/doi.org\/10.3389\/fcvm.2018.00085","journal-title":"Front Cardiovasc Med"},{"issue":"2","key":"2502_CR26","doi-asserted-by":"publisher","first-page":"125","DOI":"10.1016\/j.jcct.2013.02.003","volume":"7","author":"R Rajani","year":"2013","unstructured":"Rajani R, Shmilovich H, Nakazato R, Nakanishi R, Otaki Y, Cheng VY, Hayes SW, Thomson LE, Friedman JD, Slomka PJ, Min JK, Berman DS, Dey D (2013) Relationship of epicardial fat volume to coronary plaque, severe coronary stenosis, and high-risk coronary plaque features assessed by coronary CT angiography. J Cardiovasc Comput Tomogr 7(2):125\u2013132. https:\/\/doi.org\/10.1016\/j.jcct.2013.02.003","journal-title":"J Cardiovasc Comput Tomogr"},{"issue":"6","key":"2502_CR27","doi-asserted-by":"publisher","DOI":"10.1161\/JAHA.120.018080","volume":"10","author":"W Yu","year":"2021","unstructured":"Yu W, Liu B, Zhang F, Wang J, Shao X, Yang X, Shi Y, Wang B, Xu Y, Wang Y (2021) Association of epicardial fat volume with increased risk of obstructive coronary artery disease in Chinese patients with suspected coronary artery disease. J Am Heart Assoc 10(6):e018080. https:\/\/doi.org\/10.1161\/JAHA.120.018080","journal-title":"J Am Heart Assoc"},{"key":"2502_CR28","doi-asserted-by":"publisher","first-page":"3","DOI":"10.3389\/fphys.2018.00003","volume":"9","author":"K Tanaka","year":"2018","unstructured":"Tanaka K, Sata M (2018) Roles of perivascular adipose tissue in the pathogenesis of atherosclerosis. Front Physiol 9:3. https:\/\/doi.org\/10.3389\/fphys.2018.00003","journal-title":"Front Physiol"},{"key":"2502_CR29","doi-asserted-by":"publisher","first-page":"167","DOI":"10.1016\/j.ijcard.2015.03.201","volume":"186","author":"V Parisi","year":"2015","unstructured":"Parisi V, Rengo G, Pagano G, D\u2019Esposito V, Passaretti F, Caruso A, Grimaldi MG, Lonobile T, Baldascino F, De Bellis A, Formisano P, Ferrara N, Leosco D (2015) Epicardial adipose tissue has an increased thickness and is a source of inflammatory mediators in patients with calcific aortic stenosis. Int J Cardiol 186:167\u2013169. https:\/\/doi.org\/10.1016\/j.ijcard.2015.03.201","journal-title":"Int J Cardiol"},{"issue":"3","key":"2502_CR30","doi-asserted-by":"publisher","first-page":"188","DOI":"10.1177\/0218492318760692","volume":"26","author":"M Nabati","year":"2018","unstructured":"Nabati M, Favaedi M, Kheirgoo M, Yazdani J, Dabirian M (2018) Correlation between epicardial fat thickness and aortic valve sclerosis. Asian Cardiovasc Thorac Ann 26(3):188\u2013195. https:\/\/doi.org\/10.1177\/0218492318760692","journal-title":"Asian Cardiovasc Thorac Ann"},{"issue":"3","key":"2502_CR31","first-page":"262","volume":"26","author":"AAKH Mahabadi","year":"2017","unstructured":"Mahabadi AAKH, Dykun I, Balcer B, Kahlert P, Rassaf T (2017) Epicardial adipose tissue thickness independently predicts severe aortic valve stenosis. J Heart Valve Dis 26(3):262\u2013267","journal-title":"J Heart Valve Dis"}],"container-title":["The International Journal of Cardiovascular Imaging"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10554-021-02502-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s10554-021-02502-x\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10554-021-02502-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,5,31]],"date-time":"2024-05-31T13:23:48Z","timestamp":1717161828000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s10554-021-02502-x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,12,26]]},"references-count":31,"journal-issue":{"issue":"6","published-online":{"date-parts":[[2022,6]]}},"alternative-id":["2502"],"URL":"https:\/\/doi.org\/10.1007\/s10554-021-02502-x","relation":{},"ISSN":["1875-8312"],"issn-type":[{"value":"1875-8312","type":"electronic"}],"subject":[],"published":{"date-parts":[[2021,12,26]]},"assertion":[{"value":"14 October 2021","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"19 December 2021","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"26 December 2021","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"MR received speaker fees from Abbott. CWH contributes to the Advisory Board of Medtronic. WK received proctor\/speaker honoraria from Abbott, Boston Scientific, Edwards Lifesciences, and Medtronic. The other authors have nothing to disclose.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}},{"value":"The study was approved by the Local Ethics Committee of the University of Giessen, Giessen, Germany.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical approval"}}]}}